belantamab - Robuta Search

https://www.blenrephcp.com/ Treatment Option | BLENREP (belantamab mafodotin-blmf) Discover BLENREP (belantamab mafodotin-blmf). See PI including Boxed Warning. For US HCPs only. treatment option https://www.newswire.ca/news-releases/pivotal-dreamm-2-study-demonstrated-a-clinically-meaningful-overall-response-rate-with-belantamab-mafodotin-gsk2857916-for-patients-with-relapsed-refractory-multiple-myeloma-804346324.html Pivotal DREAMM-2 study demonstrated a clinically meaningful overall response rate with belantamab... Overall response rate (ORR) of 31% with 2.5 mg/kg regimen and no new safety signals in heavily pre-treated patient population who were refractory to an... https://experts.arizona.edu/en/publications/profile-and-management-of-toxicity-of-selinexor-and-belantamab-ma/ Profile and management of toxicity of selinexor and belantamab mafodotin for the treatment of... for the profile management toxicity https://www.cancer.gov/research/participate/clinical-trials/intervention/belantamab-mafodotin Clinical Trials Using Belantamab Mafodotin - NCI NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studying belantamab mafodotin. clinical trials using nci https://pubmed.ncbi.nlm.nih.gov/40763276/ Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7... Belantamab mafodotin (belamaf) combined with standard therapies demonstrated significant progression-free survival (PFS) and overall survival benefits in... https://open.library.emory.edu/concern/publications/852f77c0-d695-4791-a1a4-ed24878160b4 Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory... Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal... https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aef7c34c-fef8-407c-99c0-a68aded53c60 DailyMed - BLENREP- belantamab mafodotin injection, powder, for solution dailymed injection powder solution https://adisinsight.springer.com/trials/700364419?error=cookies_not_supported&code=28a6c5ac-caf5-48a5-82e8-21be7b92896f A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma -... This is a research study to find out if a drug called belantamab mafodotin in combination with dexamethasone, a steroid, can be safely and effectively given in collaborative community effort using https://adisinsight.springer.com/drugsafety/803927813?error=cookies_not_supported&code=2158bc75-c0b6-464c-833d-ad2aa48b3f36 Belantamab mafodotin - AdisInsight Nineteen patients [ages and sexes not stated] with relapsed or refractory multiple myeloma enrolled in a phase 1/2 study received belantamab mafodotin in adisinsight https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-belantamab-mafodotin-to-improve-treatment-for-myeloma-prommise Cancer Research UK | A trial of belantamab mafodotin to improve treatment for myeloma (ProMMise) This trial is looking at adding a drug called belantamab mafodotin to usual treatment for myeloma. cancer research uk